These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9375945)

  • 21. Beta-blockers for preventing sudden cardiac death.
    Giles TD; Basile JN
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):30-4. PubMed ID: 19667667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between antihypertensive agents, serum lipids and cigarette smoking in high risk hypertensive patients.
    Plouin PF
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():49-53; discussion 53-4. PubMed ID: 2575176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STOP-Hypertension-2 and best practice for the future.
    Hannson L
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i2-4:discussion i50. PubMed ID: 10956309
    [No Abstract]   [Full Text] [Related]  

  • 25. Current drug treatment and treatment patterns with antihypertensive drugs.
    Freis ED; Papademetriou V
    Drugs; 1996 Jul; 52(1):1-16. PubMed ID: 8799681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.
    Chen JM; Heran BS; Perez MI; Wright JM
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications.
    Wikstrand J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S64-75. PubMed ID: 11527139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of sudden cardiac death with beta blockers.
    Hjalmarson A
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V11-5. PubMed ID: 10526698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Jeffers BW; Robbins J; Bhambri R
    Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of different blood-pressure-lowering regimens on major cardiac events.
    Fuchs FD
    Lancet; 2004 Jan; 363(9405):332. PubMed ID: 14751721
    [No Abstract]   [Full Text] [Related]  

  • 34. Review of the long-term controlled trials of usefulness of therapy for systemic hypertension.
    Gifford RW
    Am J Cardiol; 1989 Jan; 63(4):8B-16B. PubMed ID: 2563189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of the month. The CAPPP study: "The Captopril Prevention Project"].
    Scheen AJ
    Rev Med Liege; 1999 Mar; 54(3):197-9. PubMed ID: 10321112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of different blood-pressure-lowering regimens on major cardiac events.
    Steffen HM; Toex U; Kolloch R
    Lancet; 2004 Jan; 363(9405):331; author reply 331-2. PubMed ID: 14751718
    [No Abstract]   [Full Text] [Related]  

  • 37. Confusing messages from the newest of the beta-blocker/diuretic hypertension trials. The Metoprolol Atherosclerosis Prevention in Hypertensives trial.
    Moser M; Sheps S
    Arch Intern Med; 1989 Oct; 149(10):2174-5. PubMed ID: 2572204
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.
    Turnbull F;
    Lancet; 2003 Nov; 362(9395):1527-35. PubMed ID: 14615107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-blockers in hypertensive and coronary heart disease.
    Goldstein S
    Arch Intern Med; 1996 Jun; 156(12):1267-76. PubMed ID: 8651834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diuretics and cardiovascular risk factors.
    Moser M
    Eur Heart J; 1992 Dec; 13 Suppl G():72-80. PubMed ID: 1486910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.